Identifiers
Database identifiers and provenance.
- Ligand ID
G4P- PDB
6czf- UniProt (similar protein)
P0AG16- Target protein
- PA3108
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 603.2
- LogP ≤ 5 -2.22
- H-bond donors ≤ 5 9
- H-bond acceptors ≤ 10 15
- Rotatable bonds ≤ 10 10
- TPSA ≤ 140 Ų 345.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)OP(=O)(O)O)O[P@](=O)(O)OP(=O)(O)O)O)N=C(NC2=O)Nc1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)OP(=O)(O)O)O[P@](=O)(O)OP(=O)(O)O)O)N=C(NC2=O)N
InChI=1S/C10H17N5O17P4/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6(30-36(26,27)32-34(21,22)23)3(29-9)1-28-35(24,25)31-33(18,19)20/h2-3,5-6,9,16H,1H2,(H,24,25)(H,26,27)(H2,18,19,20)(H2,21,22,23)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1InChI=1S/C10H17N5O17P4/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6(30-36(26,27)32-34(21,22)23)3(29-9)1-28-35(24,25)31-33(18,19)20/h2-3,5-6,9,16H,1H2,(H,24,25)(H,26,27)(H2,18,19,20)(H2,21,22,23)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1
BUFLLCUFNHESEH-UUOKFMHZSA-NBUFLLCUFNHESEH-UUOKFMHZSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF13522
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand G4P →
- PDB RCSB structure 6czf →
- UniProt UniProt P0AG16 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “G4P”) →
Other binders for this protein
Quick navigation to other ligands bound to PA3108.
PDB 9
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).